LRMR
Larimar Therapeutics Inc.
$3.62
-$0.29(-7.42%)
41
Overall
--
Value
54
Tech
28
Quality
Market Cap
$331.23M
Volume
1.40M
52W Range
$1.61 - $9.50
Target Price
$19.50
EPS Estimates Overview
| Current Quarter | $-0.4 | Next Quarter | $-0.4 |
| Current Year | $-1.66 | Next Year | $-1.61 |
| QoQ Growth | +0.0% | YoY Growth | +3.0% |
| 3Y EPS CAGR | +18.2% | Target Price | $19.50 |
| Consensus | Buy | Upside | +438.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $3.62 | -7.4% | 1.40M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW